From exploratory pilot studies to landmark multinational clinical trials spanning 85+ countries, CRLB-GMEL delivers ISO-accredited analytical and biobank services with uncompromising quality.
We are uniquely positioned to serve the complete spectrum of research — from a first feasibility study to a multi-decade global cohort — with the same expert team and ISO-accredited rigour at every scale.
Decades of experience managing specimens from 85+ countries. Our infrastructure has supported some of the most cited clinical trials in cardiovascular and population health research.
The same ISO-accredited standards, the same expert team, the same publication-quality data — available to investigator-led studies, pilot projects, and academic research collaborations of any size.
End-to-end support for the entire research lifecycle — delivering data publishable in top-tier international journals.
ISO-accredited chemistry and immunoassay panels. Publication-ready data for clinical and epidemiological research.
Learn More →Multi-platform genotyping and microarray analysis for precision medicine and population genomics.
Learn More →~3.5 million samples maintained with rigorous quality controls for long-term longitudinal studies.
Learn More →Nitrogen vapour storage at −160°C to −180°C preserving specimen integrity across decades.
Learn More →Multi-site clinical trial infrastructure with chain of custody and regulatory-compliant reporting.
Learn More →Olink Certified Service Provider. Up to 5,000 blood biomarkers from a single sample via proximity extension assay.
Learn More →Our history spans some of the most influential cardiovascular, diabetes, and population health studies ever conducted.
Whether you’re planning a global trial or a focused pilot — our team is ready to help at any scale.